Foot-and-mouth disease (FMD) is an economically significant animal disease because of the speed of its transmission. Routine vaccination may not be effective for early protection in an outbreak situation. Small interfering RNA (siRNA) can be used as a rapid, effective, and an alternative antiviral approach. In this study, we screened 15 synthetic siRNAs to inhibit FMD virus replication in IBRS-2 cells and selected 10 siRNA sequences. Furthermore, we produced 7 adenoviruses expressing shRNA targeting conserved regions of FMDV, such as a leader sequence and nonstructural protein regions, and showed their antiviral effects. We compared the antiviral effects among them and compared between synthetic siRNAs and adenovirus-delivered siRNAs. In particular, the most efficient siRNA, 3C 2 , was the conserved sequence in the O, A, Asia 1, and C serotypes of FMDV and was located in the predicted loop structure. The pool of sequences including 3C 2 and recombinant adenoviruses could be applied for multiple siRNAs and protection in a broad range of cells and animals.
INTRODUCTION
Foot-and-mouth disease (FMD) is a highly contagious disease that affects cloven-hoofed animals such as cattle, swine, and sheep (1) Adenovirus vectors have several advantages as a delivery system. They are relatively stable and easy to manipulate and can be obtained in high titers. Adenovirus vectors can be administered by various routes such as intranasal, oral, intraperitoneal, intravenous, intramuscular, and subcutaneous (13) , and therefore, can be effectively applied in animals as well. Researchers have reported inhibition of FMDV replication using adenovirus expressing RNAi (12) .
In this study, we screened fifteen small interfering RNAs (siRNAs) to inhibit FMDV replication in IBRS-2 cells and selected ten siRNA sequences. Furthermore, we produced seven adenoviruses expressing the shRNA targeting conserved regions of FMDV and showed their antiviral effects. Virus titers were determined on IBRS-2 cells for FMDV and 293A cells for adenovirus. The 50% tissue culture infective dose (TCID 50 ) was calculated using the formula of Reed and Muench (14) .
MATERIALS AND METHODS

Cells
Design and synthesis of siRNAs
The siRNAs were developed from FMDV O/SKR/2000 Table 1 . Target sequences of siRNAs used in this study
Name
Target sequence The region of FMDV (nt position) One hundred microliters of culture medium containing 2%
FBS were added and the cells were incubated at 37℃.
Supernatants were collected 48 h after FMDV infection
and were used in the replication analysis of FMDV.
Construction of plasmids
Oligonucleotides of the inverted repeat FMDV target sequence were annealed and cloned into the pENTR/U6 entry vector (Invitrogen) under the control of the U6 promoter and a termination signal consisting of six thymidines ( 
RESULTS
Inhibition of FMDV replication in IBRS-2 cells by synthesized siRNA
The relative viral protein level was measured at 48 h postinfection (p.i.) using FMDV antigen ELISA. The results
show that the relative level (%) of FMD viral protein was reduced in IBRS-2 cells transfected with siRNAs (Fig. 2 ).
Ten siRNAs showed antiviral effect compared with the negative control siRNA; the antiviral effect of the other five (2C 1 , 3D 3 , 5'U, 3D 5 , and 2C 2 ) was not statistically significant. Among the siRNAs that were found to have antiviral effect, 3C 1 , 3D 1 , 3D 2 , VP1 1 , VP1 2 , 2B, 3C 2 , 3D 4 , and L showed more than 80% reduction compared with the no treatment group (FMDV group). They showed superior The relative viral level was measured at 48 h p.i. using antigen ELISA (*p < 0.05, t-test, a statistically significant differences between negative control (con) and others). Optical density (OD) was changed to relative antigen level (%) which was percentage of sample OD to negative control OD. Error bars indicate standard deviation (SD). 
Inhibition of FMDV replication in IBRS-2 cells by adenovirus-mediated shRNA treatment
Among the siRNA sequences that showed antiviral effect, we selected those that targeted the leader protease region or the nonstructural protein, which is the conserved region that inhibits against various serotypes of FMDV replication. We constructed a recombinant adenovirus that expressed the selected siRNAs including 3C 1 , 3D 1 , 3D 2 , 2B 1 , 3C 2 , 3D 4 , and L (Fig. 1C) . In 48 h FMDV postinfection, Ad-3C 1 , Ad-3D 1 , Ad-3D 2 , Ad-2B 1 , Ad-3D 4 , and Ad-L, all showed statistically significant differences in FMDV replication (p < 0.05) (Fig. 3) . Furthermore, Ad-3C 2 (p < 0.0001) was the most effective.
Sequence alignment of 3C 2 siRNA region for seven serotypes and predicting the location of 3C 2 siRNA in
RNA structure
We analyzed the 3C 2 siRNA target sequences to anticipate against seven serotypes of FMDV (Fig. 4A) . The sequences were completely conserved between the O, A, Asia 1, and C serotypes of FMDV, but had sequence variation in the SAT 1 (two mismatches), SAT 2 (two mismatches), and SAT 3 (one mismatch) serotypes of FMDV used in this study.
Furthermore, it was predicted that the 3C 2 sequences were located in the loop structure of 3C (Fig. 4B ).
Antiviral effects of 3C 2 siRNA against O, A, and Asia
FMDV
We observed antiviral effects when the adenovirus expressing 3C 2 siRNA was applied to O, A, and Asia 1 serotypes of FMDV (Fig. 5) . We analyzed the level of (Fig. 2 and Fig. 3 ). Although synthesized siRNAs directly work in cytoplasm, shRNA must be generated in the nucleus before shRNA-mediated viral vectors are able to come out to the cytoplasm. Therefore, even if the same target sequence is expressed, the silencing effect on the target RNA may differ. In this study, 3C 2 was the most effective in approaches for both synthesized siRNA and adenovirus-mediated shRNA. Because the 3C 2 siRNA sequence was conserved in O, A, Asia 1, and C types of FMDV (Fig. 4A) , the interference was maintained in several serotypes. The alignment coincided with the antiviral effects against O, A, and Asia 1 types of FMDV (Fig. 5) . In terms of silencing efficiency, it depended on the structural environment of the target site, as well as the siRNA sequence itself (21, 22) . The hairpin structures and loops possibly contributed to the inefficacy of the siRNAs.
However, we found that the 3C 2 , targeting disordered loop regions, had high efficiency (Fig. 4B) . Furthermore, the 3C 1 sequence, the functional siRNA, was located in a hairpin structure (data not shown). In other studies, the silencing of siRNA targeting cis-acting replication element (CRE) of human enterovirus B another member of Picornaviridae was not hampered by the stem loop structure and the siRNA had a strong antiviral effect (23) .
We screened siRNA sequences in the complete genome for inhibiting FMDV replication and produced synthetic siRNAs and recombinant adenovirus expressing siRNAs.
We compared the antiviral effects among them and synthetic siRNAs with adenovirus delivered siRNAs. The pool of sequences and recombinant adenoviruses could be applied for multiple siRNAs and protection in a broad range of cells and animals. However, we did not show whether escaped mutants against the siRNAs including 3C 2 were generated and did not test the duration of the silencing effects of synthetic and adenovirus delivered siRNAs. These issues require further study.
